Management of breast cancer with hormones and drugs

M. E. Lippman

Research output: Contribution to journalArticlepeer-review


Because more than one third of patients with early breast cancer die of metastatic disease after primary local-regional treatment, systemic adjuvant therapy is often needed. Adjuvant combination chemotherapy is now standard in premenopausal women with positive axillary nodes. For postmenopausal women with positive nodes and steroid hormone receptors, endocrine therapy may be effective.

Original languageEnglish (US)
Pages (from-to)119-131
Number of pages13
JournalHospital Practice
Issue number5
StatePublished - Jan 1 1986

ASJC Scopus subject areas

  • Medicine(all)


Dive into the research topics of 'Management of breast cancer with hormones and drugs'. Together they form a unique fingerprint.

Cite this